MLC is a project at the confluence of digital health, technology, and sustainable growth, combining profitability potential, robust infrastructure, and an experienced team.
What makes MLC the investor's choice in 2026?
1. Finished technology product
CGM Fly, our in-house developed continuous glucose monitoring solution, is designed for the mass market and aims to address long-term demand in the digital health segment.
2. Manufacturing company in China: a strategic advantage
Quality control, production scalability, logistics efficiency and production cost optimization at the heart of global supply chains.
3. Protected intellectual property
A portfolio of 17 patents and intellectual property valued at over $ 108 million provides the foundation for a sustainable market position and long-term capitalization.
4. Structural growth of the global CGM market
The CGM systems segment has been demonstrating steady growth against the backdrop of digitalization of medicine and an increase in the number of patients. MLC occupies a promising niche in a fast-growing sector.
5. Scale and support of the international community
130,000+ participants from 178 countries confirm the demand for the product and viability of the business model.
6. Transparent and clear investment model
Clear terms of participation, a transparent development roadmap, and a long-term scaling strategy.
7. Fast pace of the project's development
The company has achieved key milestones in a short timeframe, demonstrating controlled growth and the ability to quickly implement strategic plans.
8. Societal relevance of investments
Investing in MLC is an investment in technologies that improve quality of life and shape the future of preventative medicine.
9. Possibility of long-term partnership
Investors gain access to a partnership model focused on long-term engagement and growing value of participation.
10. Outcome-driven management
The project is developed under the leadership of a team focused on strategic growth and creating long-term value for investors.
Join now.
On February 1, the discount on investment shares will be reduced by 20%.
Invest in the future that is being shaped today.
